Metraipolis › archive › dc_ffe436a46f3c

Symptom evolution, persistence, and pharmacological management in paediatric NMDA receptor antibody encephalitis — Europe PMC PMID:42602975

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602975
DOI
10.1016/j.bbih.2026.101320
License (as archived)
solo-consultazione
Archived
2026-10-17T06:37:31.087Z
SHA-256 of the archived text
425a3f4db2c8eea9c174592a4261d0827dce6f61958d2b6f79a61fcd1b5d771e
Stable URL of this page
https://metraipolis.com/documento/dc_ffe436a46f3c

How to cite

Symptom evolution, persistence, and pharmacological management in paediatric NMDA receptor antibody encephalitis — Europe PMC PMID:42602975 — Europe PMC (en), https://europepmc.org/article/MED/42602975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffe436a46f3c (Metraipolis archive dc_ffe436a46f3c, sha256 425a3f4db2c8eea9c174592a4261d0827dce6f61958d2b6f79a61fcd1b5d771e)
BibTeX
@misc{dcffe436a46f3c,
  title = {Symptom evolution, persistence, and pharmacological management in paediatric NMDA receptor antibody encephalitis — Europe PMC PMID:42602975},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602975},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffe436a46f3c; sha256 425a3f4db2c8eea9c174592a4261d0827dce6f61958d2b6f79a61fcd1b5d771e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602975. Agents can read the archived copy with the MCP tool read_document.